Key result
Respiratory muscle strength (Pimax) was reduced in light-chain amyloidosis patients with congestive heart failure compared to asymptomatic patients.
Observational (n=46)
Respiratory muscle weakness and ventilatory inefficiency are present in patients with light-chain amyloidosis and correlate with the severity of cardiac impairment, including diastolic dysfunction.
Answers are grounded in this paper and cite their sources.
Respiratory muscle weakness links to heart failure severity in light-chain amyloidosis; hypothesis-generating and requires prospective validation.
Background. Cardiac involvement in light-chain amyloidosis (AL) frequently results in heart failure with dyspnoea. In heart failure due to ischemic or idiopathic etiology, respiratory muscle dysfunction and ventilatory inefficiency contribute to symptoms and are independent prognostic predictors. However, in patients with AL, respiratory muscle function has not been elucidated.Methods. In 46 consecutive male patients with AL, lung function, maximal inspiratory (Pimax) and expiratory (Pemax) mouth occlusion pressures, cardiopulmonary exercise testing, echocardiography, and cardiac biomarkers were prospectively studied.Results. Pimax and Pemax were reduced, P0.1 did not differ between controls and AL. Pimax and Pemax were reduced in AL with congestive heart failure compared with asymptomatic patients (median (range) 5.4 (2.3–12.4) kPa vs 10.4 (6.5–14.0) kPa; p < 0.05). Respiratory muscle weakness occurred in systolic and diastolic LV dysfunction. Pimax was associated with peak exercise oxygen uptake, respiratory inefficiency, wall thickness, and N-terminal pro-brain natriuretic peptide.Conclusions. Respiratory muscle dysfunction and ventilatory inefficiency correlates well with intraventricular septum thickness and peak oxygen uptake and are present even in patients with diastolic dysfunction. Respiratory muscle dysfunction might contribute to dyspnea and exercise limitation and appears to represent a marker of cardiac impairment even in diastolic heart failure. Further studies of Pimax as a potential non-invasive prognostic marker are needed.
No takes yet. Share an insight, caveat, or question.
Kristen et al. (2008) conducted an observational in Light-chain amyloidosis (n=46). Congestive heart failure vs. Asymptomatic patients was evaluated on Maximal inspiratory pressure (Pimax) (p=< 0.05). Respiratory muscle strength (Pimax) was reduced in light-chain amyloidosis patients with congestive heart failure compared to asymptomatic patients.
Synapse has enriched 10 related papers. Consider them for comparative context: